Mesenchymal phenotype drives high metabolic tumor volume in pancreatic cancer: integrated transcriptomic and single-cell analysis of tumor-stroma metabolic interactions

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, largely due to late diagnosis and treatment resistance. Metabolic reprogramming is a hallmark of cancer, but the mechanisms underlying metabolic heterogeneity in PDAC remain unclear. This study aimed to explore the relationship between metabolic tumor volume (MTV) and molecular features in PDAC to identify key regulators of metabolic phenotypes. We analyzed high-throughput transcriptomic data from 14 PDAC samples with matched adjacent tissues and single-cell RNA sequencing data from 6 PDAC samples. Samples were stratified by MTV values from PET-CT imaging. Differentially expressed genes between MTV high and MTV low groups were identified and functionally annotated. Single-cell analysis characterized cell-type specific expression patterns, cell-cell communication networks, and metabolic profiles. Weighted gene co-expression network analysis (WGCNA) was used to identify key regulatory modules associated with metabolic phenotypes. PLEC expression was validated by immunohistochemistry (IHC) in an independent cohort of 8 PDAC patients. In 6 of these cases, six-marker multiplex immunofluorescence (panCK, PLEC, CD8, FOXP3, CD68, PD-L1) was performed to resolve PLEC expression within tumor and immune compartments and to characterize the spatial immune microenvironment. Comparison of MTVʰⁱᵍʰ and MTVˡᵒʷ tumors identified 73 shared differentially expressed genes, among which PLEC was the top upregulated candidate. PLEC co-expressed with extracellular matrix components and was enriched in both cancer-associated fibroblasts (CAFs) and tumor cells. At single-cell resolution, PLECʰⁱᵍʰ fibroblasts displayed a myofibroblastic, matrix-remodeling phenotype, whereas PLECʰⁱᵍʰ tumor cells showed heightened metabolic reprogramming, with enhanced glycolysis and oxidative phosphorylation. Cell-cell communication analysis implicated PTN–SDC4/SDC1, MDK–SDC1, WNT, and TGF-β signaling in PLEC-associated tumor–stroma crosstalk. IHC confirmed elevated PLEC expression in PDAC tissues. Multiplex immunofluorescence showed PLEC co-localization predominantly with panCK + tumor cells and focally with CD68 + macrophages, but not with PD-L1. Integrated bulk and single-cell transcriptomic analyses identified mesenchymal programs in CAFs and malignant epithelial cells as major correlates of MTV in PDAC, with PLEC emerging as a candidate hub gene. Spatial imaging showed enrichment of PLEC-positive and PanCK/PLEC double-positive cells in tumor regions, and IHC further confirmed PLEC expression in pancreatic tumor cells. PLEC may therefore serve as a potential molecular correlate of the metabolic phenotype in PDAC.

Authors

Institutions

Publication Details

Journal
Cancer Cell International
Published
2026-11-17
DOI
https://doi.org/10.1186/s12935-026-04510-0
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mesenchymal phenotype drives high metabolic tumor volume in pancreatic cancer: integrated transcriptomic and single-cell analysis of tumor-stroma metabolic interactions

Xiu Wang, Nan Zhou, Dajun Du, Tiantian Yang et al.
7 links
Cancer Cell International
Pancreatic and Hepatic Oncology Research
article

Mesenchymal phenotype drives high metabolic tumor volume in pancreatic cancer: integrated transcriptomic and single-cell analysis of tumor-stroma metabolic interactions

Xiu Wang, Nan Zhou, Dajun Du, Tiantian Yang, Jiahui Yuan, Zhijun Feng
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, largely due to late diagnosis and treatment resistance. Metabolic reprogramming is a hallmark of cancer, but the mechanisms underlying metabolic heterogeneity in PDAC remain unclear. This study aimed to explore the relationship between metabolic tumor volume (MTV) and molecular features in PDAC to identify key regulators of metabolic phenotypes. We analyzed high-throughput transcriptomic data from 14 PDAC samples with matched adjacent tissues and single-cell RNA sequencing data from 6 PDAC samples. Samples were stratified by MTV values from PET-CT imaging. Differentially expressed genes between MTV high and MTV low groups were identified and functionally annotated. Single-cell analysis characterized cell-type specific expression patterns, cell-cell communication networks, and metabolic profiles. Weighted gene co-expression network analysis (WGCNA) was used to identify key regulatory modules associated with metabolic phenotypes. PLEC expression was validated by immunohistochemistry (IHC) in an independent cohort of 8 PDAC patients. In 6 of these cases, six-marker multiplex immunofluorescence (panCK, PLEC, CD8, FOXP3, CD68, PD-L1) was performed to resolve PLEC expression within tumor and immune compartments and to characterize the spatial immune microenvironment. Comparison of MTVʰⁱᵍʰ and MTVˡᵒʷ tumors identified 73 shared differentially expressed genes, among which PLEC was the top upregulated candidate. PLEC co-expressed with extracellular matrix components and was enriched in both cancer-associated fibroblasts (CAFs) and tumor cells. At single-cell resolution, PLECʰⁱᵍʰ fibroblasts displayed a myofibroblastic, matrix-remodeling phenotype, whereas PLECʰⁱᵍʰ tumor cells showed heightened metabolic reprogramming, with enhanced glycolysis and oxidative phosphorylation. Cell-cell communication analysis implicated PTN–SDC4/SDC1, MDK–SDC1, WNT, and TGF-β signaling in PLEC-associated tumor–stroma crosstalk. IHC confirmed elevated PLEC expression in PDAC tissues. Multiplex immunofluorescence showed PLEC co-localization predominantly with panCK + tumor cells and focally with CD68 + macrophages, but not with PD-L1. Integrated bulk and single-cell transcriptomic analyses identified mesenchymal programs in CAFs and malignant epithelial cells as major correlates of MTV in PDAC, with PLEC emerging as a candidate hub gene. Spatial imaging showed enrichment of PLEC-positive and PanCK/PLEC double-positive cells in tumor regions, and IHC further confirmed PLEC expression in pancreatic tumor cells. PLEC may therefore serve as a potential molecular correlate of the metabolic phenotype in PDAC.

Cancer Cell International
Xinyang Normal University (CN), Shenzhen University (CN), Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN), Xinyang Central Hospital (CN)
National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon